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6. Poisoning with drugs 
All drugs are poisons.  Unfortunately, when medicines are given at higher doses than 
recommended, their effects are no longer limited to beneficial with the possibility of some 
adverse effects, but become poisonous.  Drugs of abuse are also poisonous.  Poisoning with 
drugs is a relatively common reason for attendance at the emergency department of the 
hospital.  For example, In Western Australia, there are about 500 hospital admissions for 
paracetamol poisoning each year. 
 
 6.1 Acute poisoning 
Drugs that can cause poisoning include prescription medicines, OTC (Over-The-Counter) 
medicines (complementary and alternative medicines), alcohol, herbal remedies, and illegal 
drugs. The drugs most commonly associated with fatalities are analgesics (paracetamol and 
aspirin), sedative-hypnotics/antipsychotics, antidepressants, stimulants and street drugs 
(including opioids and cocaine), and cardiovascular drugs (digoxin and Ca
2+
 entry blockers). 
 
In acute poisoning, the general symptoms are nausea, vomiting, dizziness, fitting, drowsiness, 
confusion, coma, and breathing difficulties.  Overdosage is the main reason for poisoning, 
and this overdosage can be accidental or intentional (drug abuse or self-harm). 
 
 6.2 Treatment of poisoning – general 
For most cases of poisoning, there are no specific treatments.  The medical care is to treat 
patients not the poison.  Thus, the medical care is of the symptoms, and to support the vital 
functions (breathing, circulation) of the subjects.  For a few poisons, there are specific 
treatments or specific antidotes.  After promptly, maintaining vital functions, especially if 
their impairment is imminent, other treatments can be considered.  The goals of this treatment 
is to keep concentration of drug/poison in crucial tissues as low as possible by preventing 
absorption and enhancing elimination, as this will obviously limit the effects of the poison.  
The second goal is to combat the pharmacological and toxicological effects at the effector 
site.   This is especially important when it is not possible to get rid of the poison quickly.  
Examples of ways to prevent absorption, enhance elimination, and to combat the 
pharmacological and toxicological effects are now discussed. 
 
 6.3 Preventing absorption 
The standard treatment of poisoning used to be to make the patient sick (emesis).  However, 
emesis with syrup of ipecac is now rarely used.  When used soon after the intake of certain 
drugs, emesis can be useful, but it is often difficult to ascertain when the poison was taken 
and hence how much poison is still in the stomach. 
 
In several situations, emesis can do more harm than good.  For instance, if the patient 
becomes comatose, emesis can cause aspiration of the gastric contents.  Similarly, if the 
patient is delirious, aspiration can occur.  Aspiration is when the contents of the stomach are 
delivered to the lung, and can be fatal.  Also, if the patient has ingested a central stimulant, 
and is delirious or has hallucinations, the further stimulation associated with vomiting may 
precipitate convulsions. 
 
Syrup of ipecac is derived from a plant source, and is available on prescription or OTC 
(Over-The-Counter).  It has both a local irritant effect on enteric tract and stimulates the 
chemoreceptor trigger zone (CTZ) or emetic centre in the area postrema of the medulla to 
induce emesis.  Syrup of ipecac is indicated when it can be administered to conscious, alert 
patients within 60 minutes of poisoning, and produces vomiting in 15-30 minutes 
 
In addition to emesis, there are two other ways to limit drug absorption.  The first is gastric 
lavage, which is restricted to patients who have taken a life-threatening amount of drug 
within the last 60 min.  For gastric lavage, a tube and large syringe are required.  The 
contents of the stomach are aspirated (sucked up), and then the stomach is lavaged (washed) 
with saline. 
 
The second alternative to emesis is activated charcoal. Activated charcoal adsorbs many 
drugs preventing their absorption and toxicity.  Activated charcoal, does not need to be 
removed artificially, nature can takes its course.  The use of activated charcoal has increased 
recently.  It is indicated for life-threatening amounts of the anti-epileptic drug 
carbamazepine.  
 
 6.4 Enhancing elimination 
The first example of a drug that it is possible to enhance elimination is paracetamol.  A 
minor metabolite of paracetamol NAPQI is extremely toxic to the liver.  Normally most of 
the paracetamol is conjugated and excreted (Figure 6.1).  However, with high poisonous 
levels of paracetamol, the glutathione (GSH) becomes depleted, and NAPQI levels increase.  
N-Acetylcysteine provides a source of GSH to promote the elimination of NAPQI.  GSH 
may also combine with NAPQI to reduce the toxicity to this compound, and hence to 
paracetamol (Figure 6.1). 
 
Figure 6.1 Promoting elimination of NAPQI (Copyright QUT, Sheila Doggrell) 
 
Another way to promote the elimination of drugs is to increase their ionisation, as ionised 
drugs are readily excreted.  For instance, aspirin is a weak acid and is readily reabsorbed 
from kidney tubule.  Thus, aspirin is recycled and remains poisonous.  Urine alkalinization 
with sodium bicarbonate increases the ionization of aspirin, and ionized aspirin is readily 
eliminated.   The enhanced elimination of aspirin reduces its toxicity.   
 
 6.5 Combating pharmacological and toxicological effects 
There are a number of ways of combating pharmacological and toxicological effects of drugs.  
For instance, as discussed in Section 3.5, hemodialysis (cleaning of the blood) can be used to 
remove drugs with low volume of distribution e.g. heparin.  This is because drugs with a low 
volume of distribution are largely confined to the plasma and can be removed by 
heamodialysis.  Drugs with high volume of distribution e.g. the antidepressant nortriptyline, 
and the lipid soluble drugs, cannot be removed with haemodialysis.  
 
Another approach is competitive reversible antagonism.  For example, naloxone is a 
competitive reversible antagonist at opioid μ receptors, which are the receptors that morphine 
stimulates.  Morphine stimulates opioid μ receptors to be analgesic.  With high doses of 
morphine, the stimulation of opioid μ receptors can cause excessive respiratory depression.  
The opioid μ receptor competitive reversible antagonist naloxone can be used to overcome 
excessive respiratory depression with morphine. 
 
For some poisons, specific antidotes have been developed.  For instance, in life-threatening 
digoxin intoxication, anti-digoxin immunotherapy can be used to combine with the digoxin 
and inactivate it.  Digoxin is used in the treatment of heart failure.  Digoxin has a low 
therapeutic index (overlap of therapeutic and toxic levels).  Toxicity with digoxin includes 
life threatening cardiac arrhythmias.  In life-threatening digoxin intoxication, anti-digoxin 
immunotherapy is used.  The anti-digoxin immunotherapy combines with digoxin to 
inactivate it  
 
Finally, chemical antagonism can be used to combat toxicological effects.  The best known 
example of chemical antagonist is to heparin.  Thus, heparin induced life-threatening 
hemorrhage can be overcome with chemical antagonism.  Heparin is strongly acidic.  
Protamine sulphate is strongly basic.  Heparin and protamine combine and the combined 
product is inactive.  
 
